跳至主要内容
临床试验/NCT00846339
NCT00846339已完成4 期

[11C] Raclopride PET Imaging Study That Investigates Relation Between Occupancy of Dopamine D2 Receptors and Genotypes of DRD2 After Bupropion Administration

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2008年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
12
试验地点
1
主要终点
Dopamine receptor occupancy

研究概览

简要总结

Bupropion has different effects on D2 dopamine receptors according to genotype.

详细描述

Open, one arm, single sequence, 2-period, study stratified into 2 DRD2 genotype groups For subjects who volunteer to cease smoking, genotypes are investigated. Twelve subjects are enrolled (6 - DRD2 Taq1A1 allele, 6 - DRD2 Taq1A2 homozygotes). Subjects receive baseline raclopride PET (High Specific Activity, Low Specific Activity).

  • Period 1 Subjects receive 150 mg of bupropion SR every day. After 1 week of medication, pharmacokinetic and PET studies are performed.
  • Period 2 Subjects receive 150 mg of bupropion SR twice a day. After 1 week of medication, pharmacokinetic and PET studies are performed.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Active smoker (more than 10 cigarettes per day for the past 2 years)

排除标准

  • Medical or psychiatric co-morbidity
  • Hypersensitive to bupropion

研究组 & 干预措施

1

Experimental

DRD2 Taq1A1 allele

干预措施: Bupropion (Drug)

2

Experimental

DRD Taq1 A2 homozygote2

干预措施: Bupropion (Drug)

结局指标

主要结局

Dopamine receptor occupancy

时间窗: 1 week

次要结局

  • Pharmacokinetic parameters of bupropion and hydroxybupropion(1 week)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验